27863129 28956320 25989955 28232667 33647242 34991300 28035532 33884958 26202202 32156555 25736874 27288826 33068562 33891302 30380028 34768690 30697974 31046160 27941249 27941250 32252218 27288456 27894106 35098494 29371863 28398233 29143554 3090444 - Search Results

Year	Number of Results
2015	4
2016	11
2017	6
2018	5
2019	4
2020	5
2021	10
2022	2

1

Mechanisms of obesity in Prader-Willi syndrome.

Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG. Khan MJ, et al. Pediatr Obes. 2018 Jan;13(1):3-13. doi: 10.1111/ijpo.12177. Epub 2016 Nov 10. Pediatr Obes. 2018. PMID: 27863129 Review.

2

Oxytocin and Prader-Willi Syndrome.

Kabasakalian A, Ferretti CJ, Hollander E. Kabasakalian A, et al. Curr Top Behav Neurosci. 2018;35:529-557. doi: 10.1007/7854_2017_28. Curr Top Behav Neurosci. 2018. PMID: 28956320 Review.

3

Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.

Kuppens RJ, Diène G, Bakker NE, Molinas C, Faye S, Nicolino M, Bernoux D, Delhanty PJ, van der Lely AJ, Allas S, Julien M, Delale T, Tauber M, Hokken-Koelega AC. Kuppens RJ, et al. Endocrine. 2015 Dec;50(3):633-42. doi: 10.1007/s12020-015-0614-x. Epub 2015 May 20. Endocrine. 2015. PMID: 25989955 Free PMC article.

4

The cellular and molecular bases of leptin and ghrelin resistance in obesity.

Cui H, López M, Rahmouni K. Cui H, et al. Nat Rev Endocrinol. 2017 Jun;13(6):338-351. doi: 10.1038/nrendo.2016.222. Epub 2017 Feb 24. Nat Rev Endocrinol. 2017. PMID: 28232667 Free PMC article. Review.

5

Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction.

Tauber M, Hoybye C. Tauber M, et al. Lancet Diabetes Endocrinol. 2021 Apr;9(4):235-246. doi: 10.1016/S2213-8587(21)00002-4. Epub 2021 Feb 26. Lancet Diabetes Endocrinol. 2021. PMID: 33647242 Review.

6

Prader-Willi syndrome: an update on obesity and endocrine problems.

Kim SJ, Cho SY, Jin DK. Kim SJ, et al. Ann Pediatr Endocrinol Metab. 2021 Dec;26(4):227-236. doi: 10.6065/apem.2142164.082. Epub 2021 Dec 31. Ann Pediatr Endocrinol Metab. 2021. PMID: 34991300 Free PMC article.

7

Ghrelin and Motilin Control Systems in GI Physiology and Therapeutics.

Sanger GJ, Broad J, Callaghan B, Furness JB. Sanger GJ, et al. Handb Exp Pharmacol. 2017;239:379-416. doi: 10.1007/164_2016_104. Handb Exp Pharmacol. 2017. PMID: 28035532 Review.

8

Appetite- and weight-inducing and -inhibiting neuroendocrine factors in Prader-Willi syndrome, Bardet-Biedl syndrome and craniopharyngioma versus anorexia nervosa.

Vlaardingerbroek H, van den Akker ELT, Hokken-Koelega ACS. Vlaardingerbroek H, et al. Endocr Connect. 2021 May 19;10(5):R175-R188. doi: 10.1530/EC-21-0111. Endocr Connect. 2021. PMID: 33884958 Free PMC article. Review.

9

Progress in Small Molecule and Biologic Therapeutics Targeting Ghrelin Signaling.

McGovern KR, Darling JE, Hougland JL. McGovern KR, et al. Mini Rev Med Chem. 2016;16(6):465-80. doi: 10.2174/1389557515666150722101329. Mini Rev Med Chem. 2016. PMID: 26202202 Review.

10

Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.

Wevrick R. Wevrick R. Physiol Behav. 2020 May 15;219:112864. doi: 10.1016/j.physbeh.2020.112864. Epub 2020 Mar 7. Physiol Behav. 2020. PMID: 32156555 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results